GC Pharma Marks 'World Hemophilia Day'
The Company Joins the Bleeding Disorder's Community to Celebrate
YONGIN, South Korea, April 15, 2019 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation), a South Korean biopharmaceutical company, joins World Hemophilia Day, observed annually by the World Federation of Hemophilia (WFH) and the global hemophilia community to raise awareness of the disease and other bleeding disorders. This year's slogan is "Reaching out: The First Step to Care". With this slogan, the global bleeding disorder's community focuses on the the importance of improving interest and awareness of hemophilia.
As part of GC Pharma's continued support of the hemophilia community, the company features this year's slogan image on its global website and giant exterior façade of its main campus in Yongin, South Korea.
"GC Pharma is proud to support the global hemophilia community in honouring World Hemophilia Day," said EC Huh, Ph. D., president of GC Pharma. "We will also strive to develop innovative drugs to make a difference in the lives of people with bleeding disorders."
World Hemophilia Day (WHD) occurs each year on April 17. Since its creation in 1989, WHD has served as an opportunity to increase awareness of hemophilia and other bleeding disorders.
Hemophilia is a congenital disorder that causes longer-than-normal bleeding due to absent or deficient clotting factor in the blood. Hemophilia A is more common than hemophilia B; hemophilia A affects about 150,000 people, whereas hemophilia B affects about 30,000 people worldwide. Treatment regimens typically include on-demand and/or regular prophylactic infusions of factor replacement therapy to control or prevent the risk of bleeding. People with hemophilia, working closely with their healthcare professionals, can live healthy lives with proper care and adequate treatment.
About GC Pharma
GC Pharma (formerly known as Green Cross Corporation) is a biopharmaceutical company that delivers life-saving and life-sustaining protein therapeutics and vaccines. Headquartered in South Korea, GC Pharma is the largest plasma protein product manufacturer in Asia and has been dedicated to quality healthcare solutions for more than half a century. Green Cross Corporation updated its corporate brand to GC Pharma in early 2018. Green Cross Corporation remains the company's registered, legal name.
View original content to download multimedia:http://www.prnewswire.com/news-releases/gc-pharma-marks-world-hemophilia-day-300832513.html
SOURCE GC Pharma